Log In
Print this Print this

TransCon Growth Hormone (ACP-001)

  Manage Alerts
Collapse Summary General Information
Company Ascendis Pharma A/S
DescriptionOnce-weekly human growth hormone (hGH) prodrug that uses TransCon prodrug technology for sustained release
Molecular Target
Mechanism of ActionInsulin-like growth factor-1 (IGF-1) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today